D. Loblaw

发表

The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer.

Hans T. Chung, Liying Zhang, A. Sahgal, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.

D Andrew Loblaw, Ethan Basch, P. Kantoff, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.

A. Kiss, P. Cheung, C. Danjoux, 2012, International journal of radiation oncology, biology, physics.

Cytotoxic effect of RB 6145 in human tumour cell lines: dependence on hypoxia, extra- and intracellular pH and drug uptake.

B. Wouters, D. Acheson, L. Skarsgard, 1995, British Journal of Cancer.

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

J. Trachtenberg, D. Urbach, R. Saskin, 2010, The Journal of urology.

Wait times in prostate cancer diagnosis and radiation treatment.

S. Bondy, S. Bondy, D. Loblaw, 2010, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline.

Ronald C. Chen, S. Freedland, T. Morgan, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

J. Trachtenberg, S. Srivastava, L. Klotz, 2007, British Journal of Cancer.

Systematic Review of the Diagnosis and Management of Malignant Extradural Spinal Cord Compression: The Cancer Care Ontario Practice Guidelines Initiative’s Neuro-Oncology Disease Site Group

N. Laperriere, D. Loblaw, A. Chambers, 2006 .

Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.

Liying Zhang, K. Sixel, R. Tirona, 2008, International journal of radiation oncology, biology, physics.

Evidence-based Series 9-9 EDUCATION AND INFORMATION 2012 Malignant Extradural Spinal Cord Compression : Diagnosis and Management

N. Laperriere, D. Loblaw, A. Chambers, 2015 .

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

A. Kishan, I. Kaplan, R. Meier, 2019, JAMA network open.

Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy.

P. Cheung, C. Danjoux, E. Szumacher, 2006, International journal of radiation oncology, biology, physics.

Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging.

P. Cheung, G. Morton, D. Loblaw, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiation Oncologist Consultations Prior to Radical Prostatectomy: Disparities and Opportunities

J. Chin, B. Fisher, R. Saskin, 2021, Journal of Urology.

External beam irradiation for localized prostate cancer--the promise of hypofractionation.

P. Cheung, D. Loblaw, 2006, The Canadian journal of urology.

Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer.

Liying Zhang, L. Klotz, D. Vesprini, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.

P. Cheung, C. Danjoux, E. Szumacher, 2009, International journal of radiation oncology, biology, physics.

Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.

Jonathan Izawa, D Andrew Loblaw, John Trachtenberg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessing individual risk for prostate cancer.

D Andrew Loblaw, John Trachtenberg, Michael W Kattan, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Be it resolved that in the modern era, the best method for dose escalation is brachytherapy: The con position.

D. Loblaw, D. Loblaw, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Evaluating the tolerability of a simultaneous focal boost to the gross tumour in prostate SABR: a toxicity and quality of life comparison of two prospective trials.

P. Cheung, L. D'alimonte, N. Mittmann, 2020, International journal of radiation oncology, biology, physics.

Comparison of Biochemical and Toxicity Outcomes From a Contemporaneous Cohort Study of Low-Risk Prostate Cancer Treated With Different Radiation Techniques

Hans T. Chung, P. Cheung, L. D'alimonte, 2013 .

Systemic therapy in men with metastatic castration-resistant prostate cancer: a systematic review.

S. Hotte, E. Winquist, D. Loblaw, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Re-irradiation for locally recurrent nasopharyngeal carcinoma.

B. O'Sullivan, M. Mclean, T. Panzarella, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hans T. Chung, Liying Zhang, P. Cheung, 2011, International journal of radiation oncology, biology, physics.

Disseminated intravascular coagulation and PC-SPES: a case report and literature review.

K. Imrie, R. Choo, D. Loblaw, 2001, The Canadian journal of urology.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based Guideline.

K. Hoffman, H. Sandler, J. Efstathiou, 2018, Practical radiation oncology.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

K. Hoffman, H. Sandler, J. Efstathiou, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital Satisfaction With Doctor Questionnaire.

A. Bezjak, D. Loblaw, T. Bunston, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline.

N. Laperriere, D. Loblaw, N. Laperriere, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.

P. Cheung, C. Danjoux, E. Szumacher, 2008, International journal of radiation oncology, biology, physics.

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

D Andrew Loblaw, Ying Liu, John Trachtenberg, 2010, The Journal of urology.

A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus.

Y. Ung, Z. Kassam, R. Wong, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Timing of Androgen Deprivation Therapy for Prostate Cancer Patients after Radiation: Planned Combined Analysis of Two Randomized Phase 3 Trials

Ryan L. Smith, M. Stockler, G. Pond, 2018, International Journal of Radiation Oncology*Biology*Physics.

A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression.

N. Laperriere, D. Loblaw, M. Ford, 2012, International journal of radiation oncology, biology, physics.

Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline.

Ronald C. Chen, M. Kattan, F. Saad, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion.

E. Basch, M. Carducci, T. Oliver, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline.

Thomas J. Smith, M. Somerfield, H. Scher, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update.

J. Chin, T. Dorff, J. Efstathiou, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer.

Thomas J. Smith, D Andrew Loblaw, Thomas J Smith, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A population-based study of malignant spinal cord compression in Ontario.

W. Mackillop, N. Laperriere, D. Loblaw, 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy

E. Fokas, H. He, Musaddeque Ahmed, 2019, Journal of Translational Medicine.

New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort

M. Kattan, K. Siminovitch, J. Trachtenberg, 2011, Cancer biology & therapy.

American Society of Clinical Oncology Clinical Practice Guidelines: formal systematic review-based consensus methodology.

M. Somerfield, E. Basch, G. Lyman, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gantry-Mounted Linear Accelerator–Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer

A. Kishan, M. Scorsetti, C. Reddy, 2019, Advances in radiation oncology.

Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials.

P. Cheung, L. D'alimonte, D. Loblaw, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pain flare in patients with bone metastases after palliative radiotherapy—a nested randomized control trial

P. Warde, T. Panzarella, T. Panzarella, 2007, Supportive Care in Cancer.

Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer

Kelvin K. W. Chan, P. Cheung, J. Pignol, 2015, Radiation oncology.

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

J. Chin, M. Brundage, G. Rodrigues, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer.

J. Chin, M. Brundage, G. Rodrigues, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low-or intermediate-risk prostate cancer clinical practice guideline

J. Chin, M. Brundage, G. Rodrigues, 2013 .

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

J. Chin, M. Brundage, G. Rodrigues, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.

Ronald C. Chen, M. Cooperberg, A. Finelli, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer.

D Andrew Loblaw, Jean-Philippe Pignol, Patrick Cheung, 2005, International journal of radiation oncology, biology, physics.

Quality of life after pelvic radiotherapy with hypofractionated IMRT boost and long-term hormone therapy for locally advanced prostate cancer.

A. Kiss, P. Cheung, C. Danjoux, 2011, Journal of Clinical Oncology.

Androgen deprivation therapy for prostate cancer-review of indications in 2010.

D. Loblaw, H. Quon, 2010, Current oncology.

Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer.

D. Urbach, R. Saskin, L. Klotz, 2012, The Journal of urology.

Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.

Liying Zhang, P. Cheung, C. Danjoux, 2010, International journal of radiation oncology, biology, physics.

Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline Summary.

E. Basch, R. B. Rumble, D. Loblaw, 2014, Journal of oncology practice.

PATRIOT Trial: Randomized phase II study of prostate stereotactic body radiotherapy comparing 11 versus 29 days overall treatment time.

Liying Zhang, B. McCurdy, P. Cheung, 2015 .

Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy

I. Mills, D. McArt, S. McDade, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy.

D Andrew Loblaw, G. Morton, D. Loblaw, 2011, Brachytherapy.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline

K. Hoffman, H. Sandler, J. Efstathiou, 2019, The Journal of urology.

Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.

G Morton, P S Basran, R. Tirona, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update Summary.

J. Chin, R. B. Rumble, D. Loblaw, 2017, Journal of oncology practice.

A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer

K. Siminovitch, J. Trachtenberg, L. Klotz, 2008, Prostate Cancer and Prostatic Diseases.

Clinical Investigation : Genitourinary Cancer Quality of Life After Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer

A. Kiss, P. Cheung, C. Danjoux, 2012 .

Impact of Prophylactic Dexamethasone on Pain Flare Following Spine Stereotactic Body Radiation Therapy (SBRT)

A. Sahgal, H. Soliman, D. Loblaw, 2014 .

Capsaicin may slow PSA doubling time: case report and literature review.

D. Loblaw, R. Nam, Bojana Jankovic, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

PATRIOT Trial: Randomized Phase 2 Study of Prostate Stereotactic Body Radiation Therapy Comparing 11 Versus 29 Days Overall Treatment Time

B. McCurdy, P. Cheung, D. Vesprini, 2015 .

Hormone use after radiotherapy failure: a survey of Canadian uro-oncology specialists.

L. Klotz, T. Pickles, P. Cheung, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Brachytherapy in patients with small prostate glands.

J. Blasko, K. Wallner, W. Ellis, 2000, Techniques in urology.

Prostate cancer: current status, new developments and applications in radiotherapy.

V. Khoo, D. Loblaw, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Does the Benefit of Adjuvant Radiotherapy following Radical Prostatectomy for Pathologic T3 or Margin-positive Prostate Cancer Extend to All Pathologic Subgroups? A Meta-analysis of the Randomized Trials

I. Thompson, L. Eapen, G. Swanson, 2010 .

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

K. Hoffman, H. Sandler, J. Efstathiou, 2018, The Journal of urology.

Systemic therapy in men with metastatic castration-resistant prostate cancer: a systematic review.

S. Hotte, E. Winquist, D. Loblaw, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Functional and pharmacokinetic outcomes after a single intravenous infusion of recombinant human erythropoietin in patients with malignant extradural spinal cord compression.

C. Wong, E. Chen, D. Loblaw, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Empowering Patients Through Education—Development and Evaluation of a Multimedia Patient Education Tool to Ensure Patient Preparedness for Planning CT Scan for Prostate Cancer (Randomized Study)

P. Cheung, E. Szumacher, Xingshan Cao, 2016 .

Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.

J. Chin, M. Brundage, G. Rodrigues, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using national cancer institute expanded common toxicity criteria.

P. Cheung, C. Danjoux, E. Szumacher, 2008, International journal of radiation oncology, biology, physics.

Utility of Incorporating Genetic Variants for the Early Detection of Prostate Cancer

K. Siminovitch, J. Trachtenberg, L. Klotz, 2009, Clinical Cancer Research.

Comparison of acute toxicity in patients treated with a 4-field box or IMRT to deliver elective pelvic nodal irradiation for localized high-risk prostate cancer.

Liying Zhang, A. Sahgal, P. Cheung, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Opportunity lost and found: Any easy way to improve outcomes for prostate cancer patients in the postoperative setting?

D. Loblaw, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.

P. Cheung, C. Danjoux, E. Szumacher, 2009, International journal of radiation oncology, biology, physics.

Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.

Liying Zhang, K. Sixel, R. Tirona, 2008, International Journal of Radiation Oncology, Biology, Physics.

Gleason upgrading with time in a large, active surveillance cohort with long-term follow-up.

L. Klotz, D. Vesprini, D. Loblaw, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.